Two Sigma Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-22,900
Closed -$1.47M 2707
2018
Q4
$1.47M Sell
22,900
-118,900
-84% -$8.78M 0.02% 486
2018
Q3
$12.7M Sell
141,800
-143,300
-50% -$12.7M 0.08% 164
2018
Q2
$22.6M Buy
285,100
+44,600
+19% +$3.7M 0.11% 136
2018
Q1
$21.5M Buy
240,500
+214,200
+814% +$20.6M 0.12% 141
2017
Q4
$2.75M Buy
+26,300
New +$2.97M 0.07% 204

Other funds holding CELG

Two Sigma Securities's CELG Position: Q4 2019 in Review

Two Sigma Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,918 shares — an estimated $687K sold.

Two Sigma Securities first reported a position in CELG in Q4 2014 and held it in 14 quarters. The position peaked at $3.15M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Two Sigma Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Securities sold 6,918 Celgene Corp shares in Q4 2019, an estimated $687K.
  • Two Sigma Securities first reported a position in Celgene Corp in Q4 2014 and held it in 14 quarters.
  • Two Sigma Securities's Celgene Corp position peaked at $3.15M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Two Sigma Securities's 13F filing for Q4 2019, filed 14 Feb 2020.